Japan · 
Who invested in Toregem BioPharma?
Toregem BioPharma's investors include Miraidoa, Kyoto University Innovation Capital Co., Ltd and Astella.
202420252026
$2.6MSeries A$5.3MVentureJapan · Venture startup
Who invested in Toregem BioPharma
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 7 months ago
Funding summaryUpdated 26 Oct 2026
$7.9Mraised across 2 rounds since 2023, from 2 sources
$2.6MSeries A$5.3MVenture
- Latest round
- Venture, $5.3MApr 2026
- Step-upi
- 2×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $2.6M Jul 2023
- Biggest round
- $5.3M Venture · Apr 2026
- Between rounds
- 2.8 years from the last two
The rounds
- Apr 2026
- Jul 2023
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
MiraidoaInvestment firm2rounds
Missing a round, or an investor who was in one? Tell us.
Quick answers about Toregem BioPharma
How much has Toregem BioPharma raised?
Toregem BioPharma has raised $7.9M across 2 rounds since 2023.
When did Toregem BioPharma last raise?
Toregem BioPharma's most recent round was a Venture of $5.3M in Apr 2026.
What was Toregem BioPharma's biggest round?
Its most recent round, $5.3M in Apr 2026, is also its largest on record.
Who backed Toregem BioPharma first?
Toregem BioPharma's first round on record, in Jul 2023, was backed by Miraidoa, Kyoto University Innovation Capital Co., Ltd and Astella.
What stage is Toregem BioPharma at?
Toregem BioPharma's latest named round is a Venture, in Apr 2026.
Where is Toregem BioPharma based?
Toregem BioPharma is based in Japan.
Companies like Toregem BioPharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.